Canada markets closed

Rakovina Therapeutics Inc. (RKV.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0900+0.0050 (+5.88%)
At close: 03:12PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 5.94M
Enterprise Value 6.44M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.37
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.32

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3-43.33%
S&P500 52-Week Change 325.01%
52 Week High 30.1600
52 Week Low 30.0050
50-Day Moving Average 30.0783
200-Day Moving Average 30.0904

Share Statistics

Avg Vol (3 month) 372.28k
Avg Vol (10 day) 354.05k
Shares Outstanding 569.83M
Implied Shares Outstanding 669.83M
Float 837.77M
% Held by Insiders 145.76%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 41.24k
Short Ratio (Apr 15, 2024) 40.01
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Feb 29, 2024) 4300

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.37%
Return on Equity (ttm)-46.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.94M
Net Income Avi to Common (ttm)-2.54M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)813.33k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)1.31M
Total Debt/Equity (mrq)30.37%
Current Ratio (mrq)6.39
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-1.93M
Levered Free Cash Flow (ttm)-1.02M